Inactive Instrument
Company Constellation Pharmaceuticals, Inc.
Stocks
CNST
US2103731061
Biotechnology & Medical Research
Business description: Constellation Pharmaceuticals, Inc.
Number of employees: 154
Sales by Activity: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Geographical breakdown of sales: Constellation Pharmaceuticals, Inc.
| Fiscal Period: December | 2019 (USD) | 2020 (USD) |
|---|
Executive Committee: Constellation Pharmaceuticals, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
John McKenna
PSD | President | - | - |
Kia Khalaghpour
IRC | Investor Relations Contact | - | - |
Irina Apostolou
PRN | Corporate Officer/Principal | - | 01/08/2016 |
Brenda J. Sousa
COO | Chief Operating Officer | 62 | 01/04/2017 |
Composition of the Board of Directors: Constellation Pharmaceuticals, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 15/07/2021 | |
John McKenna
BRD | Director/Board Member | - | - |
Company details: Constellation Pharmaceuticals, Inc.
Bio Therapeutic Drugs
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.41% | -2.07% | +41.26% | +95.40% | 6.9TCr | |
| -1.67% | +0.22% | +42.10% | +88.92% | 6.63TCr | |
| +0.15% | +6.98% | -11.03% | +380.91% | 2.77TCr | |
| +0.51% | +1.04% | -0.35% | -15.46% | 2.58TCr | |
| -3.00% | -2.90% | +39.40% | +9.41% | 2.65TCr | |
| -0.91% | +1.21% | +25.04% | -18.06% | 2.04TCr | |
| +3.45% | -13.46% | +222.69% | +389.50% | 1.76TCr | |
| -1.49% | -4.88% | -0.41% | +530.26% | 1.51TCr | |
| -0.81% | +8.24% | +57.66% | +164.64% | 1.47TCr | |
| Average | -0.37% | -1.37% | +46.26% | +180.61% | 3.15TCr | |
| Weighted average by Cap. | -0.48% | -0.83% | +41.13% | +140.57% |
